Defaults | Sample Size | Highly Variable Drugs / Drug Products | EMA | Health Canada | Gulf Cooperation Council | FDA | Narrow Therapeutic Index Drugs (FDA, CDE) | Highly Variable Narrow Therapeutic Index Drugs (FDA, CDE) | Power | Type I Error | Iteratively adjusted α | ‘Exact’ Procedure | Helpers | BE limits | Expanded Limits (EMA, Health Canada), widened limits (GCC) | ‘Implied’ Limits | Limits of the ‘desired consumer risk model’ | Regulatory Settings | Authors | License

Defaults | Sample size | Example 1 | Example 2 | Example 3 | Basic | Advanced | Example 4 | Example 5 | Higher-Order Designs | Power | Pooling | Hints | Power Analysis | Dropouts | Literature Data | Direction of Deviation | Authors | License

Example 1 | Non-Superiority | Example 2 | Bracketing Approach | Author | License

Function pa.ABE() | Function pa.scABE() | Function pa.NTIDFDA() | Examples | Average Bioequivalence | Reference-scaled Average Bioequivalence | Highly Variable Drugs / Drug Products | EMA | Health Canada | Gulf Cooperation Council | FDA, CDE | Narrow Therapeutic Index Drugs (FDA, CDE) | Cave! | Authors | License

Defaults | Examples | Cave! | Author | License

Introduction | Abbreviations, Definition of Terms, Models | A Note on Rounding | Installation | Contributors | License